These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4372368)

  • 21. The induction of tumour immunity in mice using glutaraldehyde-treated tumor cells.
    Sanderson CJ; Frost P
    Nature; 1974 Apr; 248(5450):690-1. PubMed ID: 4208483
    [No Abstract]   [Full Text] [Related]  

  • 22. Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice.
    Check JH; Brady LW; Leipold PL; O'Neill EA
    Cancer; 1974 Jul; 34(1):197-203. PubMed ID: 4834179
    [No Abstract]   [Full Text] [Related]  

  • 23. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):137-47. PubMed ID: 4348218
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunization against SV40 tumor virus; antigenic relationship between embryonic hamster cells and cells transformed by SV40].
    Houle G; Richer G; Dubreuil R; Borduas AG
    Can J Microbiol; 1974 Mar; 20(3):379-83. PubMed ID: 4362600
    [No Abstract]   [Full Text] [Related]  

  • 25. [On a simple method of "immunization" against cancer--an expanded reproduction attempt].
    Schmidt F
    Krebsarzt; 1968; 23(2):91-3. PubMed ID: 4301924
    [No Abstract]   [Full Text] [Related]  

  • 26. Recovery with immunity after serial tapping of transplantable mouse ascites tumours.
    Apffel CA; Arnason BG; Twinam CW; Harris CA
    Br J Cancer; 1966 Mar; 20(1):122-6. PubMed ID: 5936672
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancement of radiation effects by heating of the tumor.
    Yerushalmi A; Har-Kedar I
    Isr J Med Sci; 1974 Jul; 10(7):772-6. PubMed ID: 4368681
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.
    Williams WH; Krueger RG
    J Natl Cancer Inst; 1972 Dec; 49(6):1613-20. PubMed ID: 4119165
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of immune responses to spontaneous hamster lymphomas.
    Vasa-Thomas KA; Ambrose KR; Bellomy BB; Coggin JH
    J Natl Cancer Inst; 1977 May; 58(5):1287-93. PubMed ID: 67210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attempts at the autologous prevention and therapy of experimental cancer.
    Nastac E; Stoian M; Hozoc M; Chira M
    Virologie; 1982; 33(1):17-21. PubMed ID: 7072146
    [No Abstract]   [Full Text] [Related]  

  • 32. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5056574
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

  • 34. Progressive growth of transplanted tumors is accompanied by increasing serum concentrations of murine gamma fetal antigen.
    Higgins PJ; Marucs S; Hawrylko E
    Oncodev Biol Med; 1981; 2(1-2):77-87. PubMed ID: 6795603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host response to premalignant mammary tissues.
    Slemmer G
    Natl Cancer Inst Monogr; 1972 Dec; 35():57-71. PubMed ID: 4659058
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunization of mice against transplantable tumor.
    Kay ER
    Experientia; 1973 Jun; 29(6):710-1. PubMed ID: 4718721
    [No Abstract]   [Full Text] [Related]  

  • 37. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 38. INTERRUPTION OF SV-40 VIRUS TUMORIGENESIS USING IRRADIATED HOMOLOGOUS TUMOR ANTIGEN.
    GOLDNER H; GIRARDI AJ; LARSON VM; HILLEMAN MR
    Proc Soc Exp Biol Med; 1964 Dec; 117():851-7. PubMed ID: 14244973
    [No Abstract]   [Full Text] [Related]  

  • 39. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of membrane fractions with enhanced tumor-transplantation-antigen activity from tumor cells infected with influenza virus.
    Boone CW; Orme TW; Blackman K; Gillette R
    J Natl Cancer Inst; 1973 Oct; 51(4):1141-4. PubMed ID: 4355600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.